UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 138

Sortiert nach

Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate

Genes chromosomes & cancer, 2008-07, Vol.47 (7), p.565-572

2008

Link zum Volltext

Verfügbarkeit prüfen

The Dual Serotonin and Noradrenaline Reuptake Inhibitor Duloxetine for the Treatment of Interstitial Cystitis: Results of an Observational Study

The Journal of urology, 2007-02, Vol.177 (2), p.552-555

2007

Link zum Volltext

Verfügbarkeit prüfen

Multimodal Perioperative Management—Combining Thoracic Epidural Analgesia, Forced Mobilization, and Oral Nutrition—Reduces Hormonal and Metabolic Stress and Improves Convalescence After Major Urologic Surgery

Anesthesia and analgesia, 2001-06, Vol.92 (6), p.1594-1600

2001

Link zum Volltext

Verfügbarkeit prüfen

Tumor percentage but not number of tumor foci predicts disease-free survival after radical prostatectomy especially in high-risk patients

Urologic oncology, 2014-05, Vol.32 (4), p.403-412

2014

Link zum Volltext

Verfügbarkeit prüfen

LONG-TERM RESULTS OF AMITRIPTYLINE TREATMENT FOR INTERSTITIAL CYSTITIS

The Journal of urology, 2005-11, Vol.174 (5), p.1837-1840

2005

Link zum Volltext

Verfügbarkeit prüfen

VEGF-C, VEGF-D and Flt-4 in Transitional Bladder Cancer: Relationships to Clinicopathological Parameters and Long-term Survival

Anticancer research, 2007-09, Vol.27 (5A), p.3127-3133

2007

Link zum Volltext

Verfügbarkeit prüfen

LONG-TERM RESULTS OF TRIGONE-PRESERVING ORTHOTOPIC SUBSTITUTION ENTEROCYSTOPLASTY FOR INTERSTITIAL CYSTITIS

The Journal of urology, 2002-02, Vol.167 (2), p.603-607

2002

Link zum Volltext

Verfügbarkeit prüfen

The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer

International journal of urology, 2008-07, Vol.15 (7), p.607-611

2008

Link zum Volltext

Verfügbarkeit prüfen

The endothelin axis in urologic tumors: mechanisms of tumor biology and therapeutic implications

Expert review of anticancer therapy, 2006-01, Vol.6 (1), p.73-81

2006

Link zum Volltext

Verfügbarkeit prüfen

A PROSPECTIVE, RANDOMIZED, PLACEBO CONTROLLED, DOUBLE-BLIND STUDY OF AMITRIPTYLINE FOR THE TREATMENT OF INTERSTITIAL CYSTITIS

The Journal of urology, 2004-08, Vol.172 (2), p.533-536

2004

Link zum Volltext

Verfügbarkeit prüfen

Phase 3 Study of Adjuvant Radiotherapy Versus Wait and See in pT3 Prostate Cancer: Impact of Pathology Review on Analysis

European urology, 2013-08, Vol.64 (2), p.193-198

2013

Link zum Volltext

Verfügbarkeit prüfen

Semi-Quantitative Immunochromatographic Test for Prostate Specific Antigen in Whole Blood: Tossing the Coin to Predict Prostate Cancer?

European urology, 2003-05, Vol.43 (5), p.478-484

2003

Link zum Volltext

Verfügbarkeit prüfen

Safety and Efficacy of Hyperbaric Oxygen Therapy for the Treatment of Interstitial Cystitis: A Randomized, Sham Controlled, Double-Blind Trial

The Journal of urology, 2006-10, Vol.176 (4), p.1442-1446

2006

Link zum Volltext

Verfügbarkeit prüfen

54 year-old female with recurrent bronchopneumonia and tumor of the left kidney

TheScientificWorld, 2004-06, Vol.4 Suppl 1, p.353-356

2004

Link zum Volltext

Verfügbarkeit prüfen

Changing treatment paradigms in the era of targeted therapies

Journal of clinical oncology, 2014-02, Vol.32 (4_suppl), p.518-518

2014

Link zum Volltext

Verfügbarkeit prüfen

The role of VEGF/mTOR/AKT pathway in patients with advanced urothelial carcinoma of the bladder cancer

Journal of clinical oncology, 2013-02, Vol.31 (6_suppl), p.264-264

2013

Link zum Volltext

Verfügbarkeit prüfen

LONG-TERM RESULTS OF TRIGONE-PRESERVING ORTHOTOPIC SUBSTITUTION ENTEROCYSTOPLASTY FOR INTERSTITIAL CYSTITIS

The Journal of urology, 2002-02, p.603-607

2002

Link zum Volltext

Verfügbarkeit prüfen

312: Long Term Results of Amitriptyline Treatment for Interstitial Cystitis

The Journal of urology, 2005-04, Vol.173 (4), p.86-86

2005

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of concurrent application of oral pentosan polysulfate and subcutaneous low-dose heparin for patients with interstitial cystitis

Urology (Ridgewood, N.J.), 2005-10, Vol.66 (4), p.707-711

2005

Link zum Volltext

Verfügbarkeit prüfen

Prospective Comparison of Sorafenib and Sunitinib for Second-Line Treatment of Cytokine-Refractory Kidney Cancer Patients

Oncology, 2008-09, Vol.74 (3-4), p.216-222

2008

Link zum Volltext

Verfügbarkeit prüfen

Pre-treatment global quality of health predicts progression free survival in metastatic kidney cancer patients treated with sorafenib or sunitinib

Journal of cancer research and clinical oncology, 2009, Vol.135 (1), p.61-67

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 138

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(127)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(134)
Berichte
(2)
Bücher
(1)
Reviews
(1)

Sprache

Englisch
(136)
Japanisch
(12)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate

The Dual Serotonin and Noradrenaline Reuptake Inhibitor Duloxetine for the Treatment of Interstitial Cystitis: Results of an Observational Study

Effect of Hospital and Surgeon Case Volume on Perioperative Quality of Care and Short-term Outcomes After Radical Cystectomy for Muscle-invasive Bladder Cancer - Results From a European Tertiary Care Center Cohort

Multimodal Perioperative Management—Combining Thoracic Epidural Analgesia, Forced Mobilization, and Oral Nutrition—Reduces Hormonal and Metabolic Stress and Improves Convalescence After Major Urologic Surgery

Tumor percentage but not number of tumor foci predicts disease-free survival after radical prostatectomy especially in high-risk patients

LONG-TERM RESULTS OF AMITRIPTYLINE TREATMENT FOR INTERSTITIAL CYSTITIS

VEGF-C, VEGF-D and Flt-4 in Transitional Bladder Cancer: Relationships to Clinicopathological Parameters and Long-term Survival

LONG-TERM RESULTS OF TRIGONE-PRESERVING ORTHOTOPIC SUBSTITUTION ENTEROCYSTOPLASTY FOR INTERSTITIAL CYSTITIS

The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer

The endothelin axis in urologic tumors: mechanisms of tumor biology and therapeutic implications

Prediction of 90-day Mortality After Radical Cystectomy for Bladder Cancer in a Prospective European Multicenter Cohort

A PROSPECTIVE, RANDOMIZED, PLACEBO CONTROLLED, DOUBLE-BLIND STUDY OF AMITRIPTYLINE FOR THE TREATMENT OF INTERSTITIAL CYSTITIS

Phase 3 Study of Adjuvant Radiotherapy Versus Wait and See in pT3 Prostate Cancer: Impact of Pathology Review on Analysis

Semi-Quantitative Immunochromatographic Test for Prostate Specific Antigen in Whole Blood: Tossing the Coin to Predict Prostate Cancer?

Safety and Efficacy of Hyperbaric Oxygen Therapy for the Treatment of Interstitial Cystitis: A Randomized, Sham Controlled, Double-Blind Trial

54 year-old female with recurrent bronchopneumonia and tumor of the left kidney

Changing treatment paradigms in the era of targeted therapies

Evidence from the ‘PROspective MulticEnTer RadIcal Cystectomy Series 2011 (PROMETRICS 2011)’ Study: How are Preoperative Patient Characteristics Associated with Urinary Diversion Type After Radical Cystectomy for Bladder Cancer?

The role of VEGF/mTOR/AKT pathway in patients with advanced urothelial carcinoma of the bladder cancer

LONG-TERM RESULTS OF TRIGONE-PRESERVING ORTHOTOPIC SUBSTITUTION ENTEROCYSTOPLASTY FOR INTERSTITIAL CYSTITIS

Laparoscopic adrenalectomy in urological centres – the experience of the German Laparoscopic Working Group

312: Long Term Results of Amitriptyline Treatment for Interstitial Cystitis

Safety and efficacy of concurrent application of oral pentosan polysulfate and subcutaneous low-dose heparin for patients with interstitial cystitis

Prospective Comparison of Sorafenib and Sunitinib for Second-Line Treatment of Cytokine-Refractory Kidney Cancer Patients

Pre-treatment global quality of health predicts progression free survival in metastatic kidney cancer patients treated with sorafenib or sunitinib

Suchergebnisse filtern